TMP Associates II LP, 10% Owner at Clarus Therapeutics Holdings, Inc. (CRXT), sold 7,477,723 shares at $2.53 ($18.9M) on 2022-04-20, disclosed to the SEC on 2022-04-25.
Open-market sale of $18.9M CRXT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.53 | 1,164 | $3K | 0.0% |
| 2 | $2.53 | 5,722 | $14K | 0.1% |
| 3 | $2.53 | 7,585 | $19K | 0.1% |
| 4 | $2.53 | 13,630 | $34K | 0.2% |
| 5 | $2.53 | 1,663,126 | $4.2M | 22.2% |
| 6 | $2.53 | 1,663,126 |
| $4.2M |
| 22.2% |
| 7 | $2.53 | 2,061,685 | $5.2M | 27.6% |
| 8 | $2.53 | 2,061,685 | $5.2M | 27.6% |
| Total | $2.53 avg | 7,477,723 | $18.9M | 100% |
| Filing → |